Paper23764751
Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
Zhang B and 11 others. Br J Cancer, 2013. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. Papers, record 23764751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23764751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
- PubMed
Topics28
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspartate-Ammonia Ligase | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Adult | |
| Animals | |
| Asparaginase | |
| Biomarkers, Tumor | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Drug Resistance, Neoplasm | |
| Female | |
| Gene Expression | |
| Humans | |
| Male | |
| Mice | |
| Mice, Nude | |
| Middle Aged | |
| Neoplasm Invasiveness | |
| Neoplasm Metastasis | |
| Neoplasm Staging | |
| Prognosis | |
| RNA Interference | |
| RNA, Small Interfering | |
| Survival | |
| Tissue Array Analysis | |
| Xenograft Model Antitumor Assays | |
| alpha-Fetoproteins |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21654208 | Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. | Autophagy | 2011 | https://conductscience.org/library/papers/21654208 | PubMed |
| 2 | 14632770 | In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia. | Br J Haematol | 2003 | https://conductscience.org/library/papers/14632770 | PubMed |
| 3 | 15970674 | TELAML1-positive ALL: a discordant genotype. | Cell Cycle | 2005 | https://conductscience.org/library/papers/15970674 | PubMed |
| 4 | 12433682 | Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. | Blood | 2003 | https://conductscience.org/library/papers/12433682 | PubMed |
| 5 | 20496989 | Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type. | Leuk Lymphoma | 2010 | https://conductscience.org/library/papers/20496989 | PubMed |
| 6 | 17088436 | Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. | Mol Cancer Ther | 2006 | https://conductscience.org/library/papers/17088436 | PubMed |
| 7 | 21351269 | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. | Int J Cancer | 2010 | https://conductscience.org/library/papers/21351269 | PubMed |
| 8 | 11415466 | Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. | Biochem J | 2001 | https://conductscience.org/library/papers/11415466 | PubMed |
| 9 | 17409444 | Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin. | Cancer Res | 2007 | https://conductscience.org/library/papers/17409444 | PubMed |
| 10 | 1972978 | A mammalian temperature-sensitive mutation affecting G1 progression results from a single amino acid substitution in asparagine synthetase. | Nucleic Acids Res | 1990 | https://conductscience.org/library/papers/1972978 | PubMed |
| 11 | 11939270 | Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation. | Int J Hematol | 2002 | https://conductscience.org/library/papers/11939270 | PubMed |
| 12 | 3470743 | Molecular cloning of a gene that is necessary for G1 progression in mammalian cells. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3470743 | PubMed |
| 13 | 10086723 | Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. | Leukemia | 1999 | https://conductscience.org/library/papers/10086723 | PubMed |
| 14 | 16156856 | Selective apoptosis of natural killer-cell tumours by l-asparaginase. | Br J Haematol | 2005 | https://conductscience.org/library/papers/16156856 | PubMed |
| 15 | 17380207 | Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17380207 | PubMed |
| 16 | 15385533 | Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15385533 | PubMed |
| 17 | 12097650 | Genomic sequences necessary for transcriptional activation by amino acid deprivation of mammalian cells. | J Nutr | 2002 | https://conductscience.org/library/papers/12097650 | PubMed |
| 18 | 21702992 | Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. | BMC Cancer | 2011 | https://conductscience.org/library/papers/21702992 | PubMed |
| 19 | 15718422 | Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. | Blood | 2005 | https://conductscience.org/library/papers/15718422 | PubMed |
| 20 | 12196214 | Childhood acute lymphoblastic leukemia. | Rev Clin Exp Hematol | 2002 | https://conductscience.org/library/papers/12196214 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42286241 | PKPD-Based Translational Modeling of Calaspargase Pegol Preclinical Activity in Hepatocellular Carcinoma. | Eur J Drug Metab Pharmacokinet | 2026 | https://conductscience.org/library/papers/42286241 | PubMed |
| 42219486 | SomaScan proteomics reveals novel biomarkers in the progression of liver cirrhosis to hepatocellular carcinoma. | BMC Med Genomics | 2026 | https://conductscience.org/library/papers/42219486 | PubMed |
| 41806079 | Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41806079 | PubMed |
| 41463097 | Asparagine synthetase (ASNS) Drives Tumorigenicity in Small Cell Lung Cancer. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463097 | PubMed |
| 41179661 | Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects. | Front Oncol | 2025 | https://conductscience.org/library/papers/41179661 | PubMed |
| 41154605 | Unveiling Metabolic Signatures as Potential Biomarkers in Common Cancers: Insights from Lung, Breast, Colorectal, Liver, and Gastric Tumours. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154605 | PubMed |
| 41074146 | Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma. | Biomark Res | 2025 | https://conductscience.org/library/papers/41074146 | PubMed |
| 40416363 | Targeting the Exonic Circular OGT RNA/O-GlcNAc Transferase/Forkhead Box C1 Axis Inhibits Asparagine- and Alanine-Mediated Ferroptosis Repression in Neuroblastoma Progression. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/40416363 | PubMed |
| 40025169 | Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications. | Exp Mol Med | 2025 | https://conductscience.org/library/papers/40025169 | PubMed |
| 39796613 | Targeting Asparagine Metabolism in Solid Tumors. | Nutrients | 2025 | https://conductscience.org/library/papers/39796613 | PubMed |
| 39378065 | CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer. | Future Oncol | 2024 | https://conductscience.org/library/papers/39378065 | PubMed |
| 39006147 | Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma. | Hepatol Forum | 2024 | https://conductscience.org/library/papers/39006147 | PubMed |
| 38959335 | Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer. | Cancer Res | 2024 | https://conductscience.org/library/papers/38959335 | PubMed |
| 38739260 | The Role of Phthalocyanine-Gold Nanoconjugates (Pc-Au NCs) in Ameliorating the Hepatic and Renal Toxicity-Induced by Silver Nanoparticles (Ag NPs) in Male Rats. | Biol Trace Elem Res | 2024 | https://conductscience.org/library/papers/38739260 | PubMed |
| 38370444 | Modifications of the GH Axis Reveal Unique Sexually Dimorphic Liver Signatures for Lcn13, Asns, Hamp2, Hao2, and Pgc1a. | J Endocr Soc | 2024 | https://conductscience.org/library/papers/38370444 | PubMed |
| 37664666 | Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of asparagine synthetase. | Oncol Lett | 2023 | https://conductscience.org/library/papers/37664666 | PubMed |
| 37108625 | Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108625 | PubMed |
| 36980965 | Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/36980965 | PubMed |
| 36914921 | Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem. | Mikrochim Acta | 2023 | https://conductscience.org/library/papers/36914921 | PubMed |
| 36618350 | Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics. | Front Immunol | 2022 | https://conductscience.org/library/papers/36618350 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| ASNS | 440 | PubTator's text mining | https://conductscience.org/library/genes/440 | NCBI Gene |
| ASPG | 374569 | PubTator's text mining | https://conductscience.org/library/genes/374569 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23764751
GET https://conductscience.org/api/papers/v1/23764751/references?page=2